209 related articles for article (PubMed ID: 25437025)
1. Independent influence of overweight and obesity on the regression of left ventricular hypertrophy in hypertensive patients: a meta-analysis.
Zhang K; Huang F; Chen J; Cai Q; Wang T; Zou R; Zuo Z; Wang J; Huang H
Medicine (Baltimore); 2014 Nov; 93(25):e130. PubMed ID: 25437025
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors.
Jaleta GN; Gudina EK; Getinet W
BMC Res Notes; 2014 Jan; 7():45. PubMed ID: 24444396
[TBL] [Abstract][Full Text] [Related]
3. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network).
Lønnebakken MT; Izzo R; Mancusi C; Gerdts E; Losi MA; Canciello G; Giugliano G; De Luca N; Trimarco B; de Simone G
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275070
[TBL] [Abstract][Full Text] [Related]
4. Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients: The Campania Salute Network.
Izzo R; Losi MA; Stabile E; Lönnebakken MT; Canciello G; Esposito G; Barbato E; De Luca N; Trimarco B; de Simone G
Hypertension; 2017 Jan; 69(1):136-142. PubMed ID: 27895192
[TBL] [Abstract][Full Text] [Related]
5. Diastolic blood pressure reduction contributes more to the regression of left ventricular hypertrophy: a meta-analysis of randomized controlled trials.
Zhang K; Chen J; Liu Y; Wang T; Wang L; Wang J; Huang H
J Hum Hypertens; 2013 Nov; 27(11):698-706. PubMed ID: 23535988
[TBL] [Abstract][Full Text] [Related]
6. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
8. Relationship of ambulatory blood pressure and body mass index to left ventricular mass index in pediatric patients with casual hypertension.
Ramaswamy P; Chikkabyrappa S; Donda K; Osmolovsky M; Rojas M; Rafii D
J Am Soc Hypertens; 2016 Feb; 10(2):108-14. PubMed ID: 26725015
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
10. Silent myocardial ischaemia in treated hypertensives with and without left ventricular hypertrophy.
Stojanovic MM; O'Brien E; Lyons S; Stanton AV
Blood Press Monit; 2003 Feb; 8(1):45-51. PubMed ID: 12604937
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
12. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.
Rodilla E; Pascual JM; Costa JA; Martin J; Gonzalez C; Redon J
J Hypertens; 2013 Aug; 31(8):1683-91. PubMed ID: 23835910
[TBL] [Abstract][Full Text] [Related]
13. The Role of Beta-Blockers in the Treatment of Hypertension.
Cruickshank JM
Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular hypertrophy in treated hypertensive patients with good blood pressure control outside the clinic, but poor clinic blood pressure control.
Cuspidi C; Michev I; Meani S; Salerno M; Valerio C; Fusi V; Bertazzoli G; Magrini F; Zanchetti A
J Hypertens; 2003 Aug; 21(8):1575-81. PubMed ID: 12872053
[TBL] [Abstract][Full Text] [Related]
15. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
16. The association between obesity, hypertension and left ventricular mass in adolescents.
Dibeklioglu SE; Çevik BŞ; Acar B; Özçakar ZB; Uncu N; Kara N; Çaycı Ş; Çakar N
J Pediatr Endocrinol Metab; 2017 Feb; 30(2):167-174. PubMed ID: 28099129
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular hypertrophy in hypertensive obese women.
Paunović K; Jakovljević B; Stojanov V
Acta Cardiol; 2006 Dec; 61(6):623-9. PubMed ID: 17205919
[TBL] [Abstract][Full Text] [Related]
18. Impact of blood pressure control on prevalence of left ventricular hypertrophy in treated hypertensive patients.
Cuspidi C; Lonati L; Sampieri L; Macca G; Michev I; Salerno M; Fusi V; Leonetti G; Zanchetti A
Cardiology; 2000; 93(3):149-54. PubMed ID: 10965085
[TBL] [Abstract][Full Text] [Related]
19. Optimal control of blood pressure can reverse left ventricular hypertrophy in uremic hypertensive hemodialysis patients.
Wu SG; Lin SL; Wu CM; Jeng FR; Su CZ
Kaohsiung J Med Sci; 1999 Feb; 15(2):62-8. PubMed ID: 10089714
[TBL] [Abstract][Full Text] [Related]
20. [Sex differences in the correlation between obesity and hypertension with left ventricular mass and hypertrophy].
Kuch B; Muscholl M; Luchner A; Döring A; Riegger GA; Schunkert H; Hense HW
Z Kardiol; 1996 May; 85(5):334-42. PubMed ID: 8711946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
